Literature DB >> 6227512

T lymphocyte subsets in patients with newly diagnosed type 1 (insulin-dependent) diabetes: a prospective study.

K Buschard, C Röpke, S Madsbad, J Mehlsen, J Rygaard.   

Abstract

T lymphocyte subsets in peripheral blood from 11 newly diagnosed Type 1 (insulin-dependent) diabetic patients were studied prospectively at three time intervals: as soon as possible after diagnosis, 3 weeks and 5 months later. Lymphocytes were marked with monoclonal OKT antibodies and examined in a fluorescence-activated cell sorter. The percentage of T lymphocytes (OKT3) did not change significantly at the three study times. The percentage of helper/inducer T cells (OKT4) was high the first week after diagnosis, but decreased at the 5-month examination (p less than 0.05). The percentage of suppressor/cytotoxic T cells (OKT8) was low at diagnosis but increased at 3 weeks (p less than 0.02) and 5 months (p less than 0.01). The ratio OKT4/OKT8 lymphocytes was 2.28 at diagnosis, decreasing to 1.77 at 3 weeks and 1.87 at 5 months, compared with 1.46 for 16 age-matched control subjects. There was no significant change in the absolute number of lymphocytes. It is concluded that the distribution of T cell subsets was abnormal at the time of diagnosis, but changed towards normal within a few weeks, after which there was no significant change at 5 months. It is as yet unknown whether the high proportion of helper/inducer T cells and/or the low percentage of suppressor/cytotoxic T cells at diagnosis favour immune reactions involved in the pathogenesis of Type 1 diabetes.

Entities:  

Mesh:

Year:  1983        PMID: 6227512     DOI: 10.1007/bf00279938

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  32 in total

1.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

2.  Functional analysis of human T cell subsets defined by monoclonal antibodies. V. Suppressor cells within the activated OKT4+ population belong to a distinct subset.

Authors:  Y Thomas; L Rogozinski; O H Irigoyen; H H Shen; M A Talle; G Goldstein; L Chess
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

3.  Enumeration of T lymphocyte subsets by monoclonal antibodies in young and aged humans.

Authors:  J E Nagel; F J Chrest; W H Adler
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

4.  Block in insulin release from column-perifused pancreatic beta-cells induced by islet cell surface antibodies and complement.

Authors:  T Kanatsuna; A Lernmark; A H Rubenstein; D F Steiner
Journal:  Diabetes       Date:  1981-03       Impact factor: 9.461

5.  Suppressor T cell function in diabetes mellitus.

Authors:  S D Horowitz; W Borcherding; G J Bargman
Journal:  Lancet       Date:  1977-12-17       Impact factor: 79.321

6.  Virus induced diabetes and the immune system. II -- Evidence for an immune pathogenesis of the acute phase of diabetes.

Authors:  F K Jansen; O Thurneyssen; H Müntefering
Journal:  Biomedicine       Date:  1979-02

7.  Virus-induced diabetes mellitus in mice and the thymus-dependent immune system.

Authors:  K Buschard; N Hastrup; J Rygaard
Journal:  Diabetologia       Date:  1983-01       Impact factor: 10.122

8.  Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes.

Authors:  S G Paik; N Fleischer; S I Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

9.  Alterations of peripheral T-lymphocyte subpopulations in patients with insulin-dependent (type 1) diabetes mellitus.

Authors:  K Buschard; C Röpke; S Madsbad; J Mehlsen; T B Sørensen; J Rygaard
Journal:  J Clin Lab Immunol       Date:  1983-03

10.  Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus.

Authors:  A A Like; A A Rossini
Journal:  Science       Date:  1976-07-30       Impact factor: 47.728

View more
  13 in total

1.  Suppression of concanavalin A-induced responses in splenic lymphocytes by activated macrophages in the non-obese diabetic mouse.

Authors:  K Yokono; Y Kawase; M Nagata; N Hatamori; S Baba
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

2.  Peripheral blood lymphocyte subpopulations in patients with primary proliferative and secondary polycythaemia.

Authors:  J T Wilde; D Barnett; M J Forrest; A C Lawrence
Journal:  J Clin Pathol       Date:  1987-02       Impact factor: 3.411

Review 3.  Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  D W Drell; A L Notkins
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

4.  Abnormalities within CD4 and CD8 T lymphocytes subsets in type 1 (insulin-dependent) diabetes.

Authors:  J Ilonen; H M Surcel; M L Käär
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

Review 5.  The role of immunotherapy in type I diabetes mellitus.

Authors:  M E Geffner; B M Lippe
Journal:  West J Med       Date:  1987-03

6.  Cell-mediated autoimmunity at the onset of insulin-dependent diabetes mellitus (IDDM).

Authors:  A G Ziegler; E Standl; T Lander; C Nerl; E P Rieber; H Mehnert
Journal:  Klin Wochenschr       Date:  1987-07-15

7.  Lymphocyte subpopulations at the onset of type 1 (insulin-dependent) diabetes.

Authors:  J Ilonen; H M Surcel; A Mustonen; M L Käär; H K Akerblom
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

8.  Spontaneous diabetes mellitus in the Bio-Breeding/Worcester rat. Evidence in vitro for natural killer cell lysis of islet cells.

Authors:  P MacKay; J Jacobson; A Rabinovitch
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

9.  T-lymphocyte subpopulations in type I diabetes mellitus. A longitudinal study.

Authors:  E R Richens; W G Jones
Journal:  Acta Diabetol Lat       Date:  1985 Jul-Sep

10.  T-lymphocyte subpopulations in insulin-dependent (type I) diabetes mellitus.

Authors:  O Pontesilli; H P Chase; P Carotenuto; M J Herberger; A R Hayward
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.